The −2549 insertion/deletion polymorphism in the promoter region of the VEGFA gene in couples with idiopathic recurrent spontaneous abortion
- 192 Downloads
The vascular endothelial growth factor A (VEGFA) is crucial for normal vasculogenesis and angiogenesis during pregnancy, and alterations in the VEGFA gene expression were detected in women with idiopathic recurrent spontaneous abortion (IRSA) and spontaneously aborted conceptuses. Our aim was to evaluate whether there is an association between the functional −2549 insertion/deletion (I/D) polymorphism in the promoter region of the VEGFA gene and IRSA in reproductive couples.
We performed a case-control study involving 149 women and their 140 partners with three or more IRSA and 149 control women and men. Allele-specific polymerase chain reaction was used for genotyping.
We found no association of the −2549 I/D polymorphism with IRSA in women. However, men with the DD genotype have a 1.75-fold increased risk of IRSA compared with men carrying the ID and II genotypes (95 % confidence interval (CI) = 1.05–2.93, P = 0.032). In addition, the D allele in men contributes to a 1.42-fold increased risk of IRSA (95 % CI = 1.02–1.97, P = 0.036) compared to men carrying the I allele.
Our results indicate that the −2549 I/D polymorphism in the VEGFA gene in men might be associated with IRSA. Additional genetic association studies including both partners, as well as expression studies, are needed to elucidate the role of this polymorphism in IRSA.
KeywordsGenetic polymorphism Pregnancy Recurrent spontaneous abortion Vascular endothelial growth factor A
This study was supported by research grants “Genetic factors in the etiology of idiopathic recurrent spontaneous abortion” (University of Rijeka, Croatia, number 13.06.1.3.32) and “Gynecology and reproduction: genomics and stem cells” (Slovenia, number P3—0326).
All procedures involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Compliance with ethical standards
The authors declare that they have no conflicts of interest.
Written informed consent was obtained from all individual participants included in the study. The study was approved by Slovenian and Croatian National Ethics’ Committees and was performed in accordance with the ethical standards as described in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
- 19.Amle D, Mir R, Khaneja A, Agarwal S, Ahlawat R, Ray PC, et al. Association of 18 bp insertion/deletion polymorphism, at -2549 position of VEGF gene, with diabetic nephropathy in type 2 diabetes mellitus patients of North Indian population. J Diabetes Metab Disord. 2015;14:19.PubMedCentralCrossRefPubMedGoogle Scholar
- 21.Allanore Y, Borderie D, Airo P, Guiducci S, Czirják L, Nasonov EL, et al. Lack of association between three vascular endothelial growth factor gene polymorphisms and systemic sclerosis: results from a multicenter EUSTAR study of European Caucasian patients. Ann Rheum Dis. 2007;66:257–9.PubMedCentralCrossRefPubMedGoogle Scholar
- 25.Asadpor U, Totonchi M, Sabbaghian M, Hoseinifar H, Akhound MR, Zari Moradi S, et al. Ubiquitin-specific protease (USP26) gene alterations associated with male infertility and recurrent pregnancy loss (RPL) in Iranian infertile patients. J Assist Reprod Genet. 2013;30:923–31.PubMedCentralCrossRefPubMedGoogle Scholar
- 32.Banerjee P, Jana SK, Pasricha P, Ghosh S, Chakravarty B, Chaudhury K. Proinflammatory cytokines induced altered expression of cyclooxygenase-2 gene results in unreceptive endometrium in women with idiopathic recurrent spontaneous miscarriage. Fertil Steril. 2013;99:179–87.CrossRefPubMedGoogle Scholar